Hu X, Chen W Y
Cancer Institute, Zhejiang Medical University, Hangzhou, China.
Zhongguo Yao Li Xue Bao. 1994 May;15(3):275-9.
A multidrug resistant variant (K562r) of the human K562 erythroleukemia cell line was obtained in vitro by repeated exposure of these cells to vincristine. The K562r cells were resistant to vincristine, harringtonine, mitomycin C, doxorubicin, epirubicin, and daunorubicin but retained the sensitivity to methotrexate. The resistances to vincristine and anthracyclines were reversed in the presence of verapamil. Despite being 60-or over 60-fold resistances to doxorubicin, epirubicin and daunorubicin, the net intracellular uptakes of these drugs at 2 h were reduced by only 15%, 20%, and 11%, respectively in K562r cells compared to their parental line. Verapamil did not enhance drug accumulation but inhibited drug efflux in K562r cells. Though there was no significant difference of drug content in cytoplasm between K562 and K562r cells, the drug content in the nucleus of K562r cells reduced significantly compared to that in K562 cells. The lower concentrations of anthracyclines in the nucleus of K562r cells might contribute to their acquisition of drug resistance.
通过将人K562白血病细胞系反复暴露于长春新碱,在体外获得了一种多药耐药变体(K562r)。K562r细胞对长春新碱、三尖杉酯碱、丝裂霉素C、阿霉素、表阿霉素和柔红霉素耐药,但对甲氨蝶呤仍敏感。在维拉帕米存在的情况下,对长春新碱和蒽环类药物的耐药性被逆转。尽管对阿霉素、表阿霉素和柔红霉素有60倍或60倍以上的耐药性,但与亲代细胞系相比,K562r细胞在2小时时这些药物的细胞内净摄取量仅分别降低了15%、20%和11%。维拉帕米并没有增强K562r细胞中的药物积累,但抑制了药物外流。虽然K562细胞和K562r细胞的细胞质药物含量没有显著差异,但与K562细胞相比,K562r细胞核中的药物含量显著降低。K562r细胞核中较低浓度的蒽环类药物可能有助于其获得耐药性。